Difference between revisions of "Cocktail bar: personalised medicine"
| Line 8: | Line 8: | ||
By 2015, old people make up around 18% of the population in the developed countries. | By 2015, old people make up around 18% of the population in the developed countries. | ||
Concerned with health care system adoptbility and the burden of the cronicle diseases of the old people on the whole society, | Concerned with health care system adoptbility and the burden of the cronicle diseases of the old people on the whole society, | ||
governments asked pharma companies to put efforts into old age diseases researches which emphasize on | governments started initiatives to asked pharma companies to put efforts into old age diseases researches which | ||
improving the quality of life and elivate the medical system burdens in the society. | emphasize on improving the quality of life and elivate the medical system burdens in the society rather than cure for | ||
desearses. | |||
Meanwhile, | With the help of IT and internet and raising awareness from the aging population, people tend to pay more attention | ||
to their own health care and maintenance. They would get a lot of medical and medicine information from websites and | |||
play more important roles in their own health. | |||
Meanwhile, big pharma teamed up with biotech companies to have fully integrated value chain.It used to be that the | |||
biotech would do all the necessary front-end research and brainwork to create and develop unique therapeutics, and | |||
pharma would use its resources to make these therapetuics to be marketable products. With bioparterning, we had the | |||
strengths of an intergrated drug development market. | |||
Revision as of 10:01, 8 October 2009
Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to contact us.
Selfcare scenario, with personalised medicine and focus on prevention, mainly driven by ageing population
Developments in time
2010-2015
The pace of aging has accelated globally especially in more developed countries. By 2015, old people make up around 18% of the population in the developed countries. Concerned with health care system adoptbility and the burden of the cronicle diseases of the old people on the whole society, governments started initiatives to asked pharma companies to put efforts into old age diseases researches which emphasize on improving the quality of life and elivate the medical system burdens in the society rather than cure for desearses.
With the help of IT and internet and raising awareness from the aging population, people tend to pay more attention to their own health care and maintenance. They would get a lot of medical and medicine information from websites and play more important roles in their own health.
Meanwhile, big pharma teamed up with biotech companies to have fully integrated value chain.It used to be that the biotech would do all the necessary front-end research and brainwork to create and develop unique therapeutics, and pharma would use its resources to make these therapetuics to be marketable products. With bioparterning, we had the strengths of an intergrated drug development market.
References: http://longevity.stanford.edu/myworld/articles/populationaging
http://www.bioworld.com/img/S08431_TOC.pdf